The non-muscle ADF/cofilin-1 controls sarcomeric actin filament integrity and force production in striated muscle laminopathies.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
24 08 2021
Historique:
received: 23 03 2020
revised: 09 06 2021
accepted: 04 08 2021
entrez: 25 8 2021
pubmed: 26 8 2021
medline: 15 2 2022
Statut: ppublish

Résumé

Cofilins are important for the regulation of the actin cytoskeleton, sarcomere organization, and force production. The role of cofilin-1, the non-muscle-specific isoform, in muscle function remains unclear. Mutations in LMNA encoding A-type lamins, intermediate filament proteins of the nuclear envelope, cause autosomal Emery-Dreifuss muscular dystrophy (EDMD). Here, we report increased cofilin-1 expression in LMNA mutant muscle cells caused by the inability of proteasome degradation, suggesting a protective role by ERK1/2. It is known that phosphorylated ERK1/2 directly binds to and catalyzes phosphorylation of the actin-depolymerizing factor cofilin-1 on Thr25. In vivo ectopic expression of cofilin-1, as well as its phosphorylated form on Thr25, impairs sarcomere structure and force generation. These findings present a mechanism that provides insight into the molecular pathogenesis of muscular dystrophies caused by LMNA mutations.

Identifiants

pubmed: 34433058
pii: S2211-1247(21)01039-1
doi: 10.1016/j.celrep.2021.109601
pmc: PMC8411111
pii:
doi:

Substances chimiques

Cofilin 1 0
DSTN protein, human 0
Destrin 0
LMNA protein, human 0
Lamin Type A 0
Mitogen-Activated Protein Kinase 1 EC 2.7.11.24
Mitogen-Activated Protein Kinase 3 EC 2.7.11.24

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109601

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests H.J.W. is on the scientific advisory board and owns equity in AlloMek Therapeutics. The remaining authors declare no competing interests.

Références

Mol Cell Biol. 2003 Jun;23(12):4401-15
pubmed: 12773579
J Appl Physiol (1985). 2006 Sep;101(3):898-905
pubmed: 16709649
Nature. 1954 May 22;173(4412):973-6
pubmed: 13165698
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Front Physiol. 2018 Oct 30;9:1533
pubmed: 30425656
J Cell Sci. 2009 Jun 15;122(Pt 12):2119-26
pubmed: 19470580
J Biol Chem. 2017 Dec 1;292(48):19565-19579
pubmed: 28939776
Nat Protoc. 2015 Jul;10(7):941-58
pubmed: 26042384
Am J Physiol Cell Physiol. 2009 Jan;296(1):C205-14
pubmed: 18945940
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Muscle Nerve. 2012 Sep;46(3):374-83
pubmed: 22907228
N Engl J Med. 1999 Dec 2;341(23):1715-24
pubmed: 10580070
Dev Cell. 2019 Oct 7;51(1):62-77.e5
pubmed: 31495694
Science. 2008 Apr 11;320(5873):239-43
pubmed: 18403713
J Cell Sci. 2013 Dec 1;126(Pt 23):5325-33
pubmed: 24293330
Hum Mol Genet. 2012 May 15;21(10):2341-56
pubmed: 22343409
J Physiol. 1958 Dec 30;144(3):403-25
pubmed: 13621405
Mol Ther. 2017 Sep 6;25(9):2038-2052
pubmed: 28663100
Hum Mol Genet. 2018 Sep 1;27(17):3060-3078
pubmed: 29878125
Dev Cell. 2014 Oct 27;31(2):215-26
pubmed: 25373779
Oncogene. 2010 Jan 14;29(2):263-72
pubmed: 19802004
J Cell Sci. 2001 Dec;114(Pt 24):4435-45
pubmed: 11792809
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Clin Genet. 1987 Nov;32(5):360-7
pubmed: 3319295
Nature. 2013 May 23;497(7450):507-11
pubmed: 23644458
Am J Physiol Regul Integr Comp Physiol. 2014 Aug 15;307(4):R444-54
pubmed: 24965795
FASEB J. 2004 Jan;18(1):102-13
pubmed: 14718391
Biostatistics. 2003 Apr;4(2):249-64
pubmed: 12925520
Bioinformatics. 2003 Feb 12;19(3):368-75
pubmed: 12584122
J Cell Sci. 2005 Apr 1;118(Pt 7):1405-16
pubmed: 15769854
Genome Biol. 2002;3(5):reviews3007
pubmed: 12049672
Cytoskeleton (Hoboken). 2010 Nov;67(11):677-92
pubmed: 20737540
Curr Biol. 2008 Apr 8;18(7):R273-5
pubmed: 18397729
Hum Mol Genet. 2011 Jun 15;20(12):2333-43
pubmed: 21441569
J Biol Chem. 1994 May 27;269(21):15280-6
pubmed: 8195165
Front Physiol. 2018 Oct 15;9:1332
pubmed: 30405424
Dev Cell. 2019 Dec 2;51(5):602-616.e12
pubmed: 31794718
Am J Physiol Cell Physiol. 2006 Feb;290(2):C411-9
pubmed: 16162659
Hum Mol Genet. 2014 Jan 1;23(1):1-11
pubmed: 23933734
Hum Mol Genet. 2005 Jan 1;14(1):155-69
pubmed: 15548545
Sci Transl Med. 2012 Jul 25;4(144):144ra102
pubmed: 22837537
Science. 1997 Jan 17;275(5298):400-2
pubmed: 8994040
Skelet Muscle. 2013 Jul 01;3(1):17
pubmed: 23815988
Nucleus. 2018 Jan 1;9(1):268-274
pubmed: 29633897
Ann Neurol. 2008 Aug;64(2):177-86
pubmed: 18551513
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
J Cell Biol. 1999 May 3;145(3):491-502
pubmed: 10225951
J Clin Invest. 2014 Aug;124(8):3529-39
pubmed: 24960163
BMC Bioinformatics. 2005 Nov 09;6:269
pubmed: 16280084
Mol Biol Cell. 2002 Jan;13(1):183-94
pubmed: 11809832
J Clin Invest. 2014 Nov;124(11):4693-708
pubmed: 25250574
Exp Biol Med (Maywood). 2004 Jun;229(6):503-11
pubmed: 15169969
Curr Biol. 2017 Jul 10;27(13):1956-1967.e7
pubmed: 28625781
Biochem Biophys Rep. 2019 Jul 12;19:100664
pubmed: 31341969
Nature. 1986 Oct 9-15;323(6088):560-4
pubmed: 3762708
Am J Hum Genet. 2007 Jan;80(1):162-7
pubmed: 17160903
Nat Genet. 1999 Mar;21(3):285-8
pubmed: 10080180
J Biol Chem. 1993 Aug 5;268(22):16321-6
pubmed: 8344919
Hum Mol Genet. 2000 May 22;9(9):1453-9
pubmed: 10814726
Nature. 2003 Dec 18;426(6968):895-9
pubmed: 14685250
J Clin Invest. 2007 May;117(5):1282-93
pubmed: 17446932
Genes Dev. 2008 Apr 1;22(7):832-53
pubmed: 18381888

Auteurs

Nicolas Vignier (N)

Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France.

Maria Chatzifrangkeskou (M)

Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France.

Luca Pinton (L)

Department of Cell and Developmental Biology, University College London, London, UK; Randall Centre for Cell and Molecular Biophysics, King's College London, London, UK.

Hugo Wioland (H)

Université de Paris, CNRS, Institut Jacques Monod, 75013 Paris, France.

Thibaut Marais (T)

Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France.

Mégane Lemaitre (M)

Sorbonne Université, UMS28, Phénotypage du Petit Animal, Paris, France.

Caroline Le Dour (C)

Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France.

Cécile Peccate (C)

Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France.

Déborah Cardoso (D)

Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France.

Alain Schmitt (A)

Université de Paris, INSERM, CNRS, Institut Cochin, 75005 Paris, France.

Wei Wu (W)

Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Maria-Grazia Biferi (MG)

Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France.

Naïra Naouar (N)

Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France.

Coline Macquart (C)

Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France.

Maud Beuvin (M)

Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France.

Valérie Decostre (V)

Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France.

Gisèle Bonne (G)

Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France.

Guillaume Romet-Lemonne (G)

Université de Paris, CNRS, Institut Jacques Monod, 75013 Paris, France.

Howard J Worman (HJ)

Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Francesco Saverio Tedesco (FS)

Department of Cell and Developmental Biology, University College London, London, UK; Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children, London, UK; The Francis Crick Institute, London, UK.

Antoine Jégou (A)

Université de Paris, CNRS, Institut Jacques Monod, 75013 Paris, France.

Antoine Muchir (A)

Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France. Electronic address: a.muchir@institut-myologie.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH